Global qPCR and dPCR Market is expected to rise from its initial estimated value of USD 3.64 billion in 2018 to a projected value of USD 7.14 billion by 2026, registering a CAGR of 8.78% in the forecast period of 2019-2026. This rise in market value can be attributed to growth in the number of novel applications of qPCR and dPCR. Global qPCR and dPCR Market By Technology (qPCR, dPCR), Products & Services (qPCR Products & Services, dPCR Products & Services), Application (qPCR Applications, dPCR Applications), End User (qPCR End Users, dPCR End Users), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Download exclusive PDF sample report @

Global qPCR and dPCR Market research report contains a quality research which has been carried out with transparent research studies. Incredible industry experience, industry insight, talent solutions and latest technology are employed while forming this report. When excellent resources from research, development, consulting, assessment, compliance and regulatory services field work together, such brilliant report is put forth for the customers. qPCR and dPCR Market report helps you get expert solutions and potential capabilities. It keeps marketplace clearly into the focus with the work, insights and analysis that has been carried out during research. Moreover, market research analysis data is presented in the detailed pattern in this report.

Key Developments in the Market:

  • In February 2019, Bio-Rad Laboratories, Inc. announced the launch of “QXDx AutoDG ddPCR System”, which incorporates company’s Bio-Rad Droplet Digital PCR technology and “QXDx BCR-ABL %IS Kit”. The products are the first US FDA cleared digital PCR products.
  • In January 2018, Thomas Scientific announced that they had acquired Denville Scientific, Inc. This acquisition will help Thomas Scientific in providing industry specific technology and solutions.

Competitive Analysis: Global qPCR and dPCR Market

Global qPCR and dPCR market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of qPCR and dPCR market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report:

  • Current and future of global qPCR and dPCR market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Customization of the Report:

  • All segmentation provided above in this report is represented at country level
  • All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

Table Of Contents: Global qPCR and dPCR Market

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

View Detailed TOC @

Leading Players:

Thermo Fisher Scientific; F. Hoffmann-La Roche Ltd; Bio-Rad Laboratories, Inc.; QIAGEN; Takara Bio Inc.; Agilent Technologies, Inc.; bioMérieux SA; Fluidigm Corporation; Danaher; Abbott; Merck KGaA; Promega Corporation; BD; Meridian Bioscience, Inc.; Analytik Jena AG; Eppendorf AG; BIONEER COPORATION; Enzo Life Sciences, Inc.,; Quantabio; Formulatrix; JN Medsys; Thomas Scientific and Biomeme, Inc.

Market Definition: Global qPCR and dPCR Market

qPCR (Quantitative Polymerase Chain Reaction), also known as Real-Time Polymerase Chain Reaction can be defined as a diagnostic technique/method. This method involves the monitoring of DNA molecule in real-time rather than at the concluding stage in conventional PCR techniques.

dPCR (Digital Polymerase Chain Reaction) is a quantitative method of measuring the presence/amount of DNA and RNA present in a particular sample. Though, the results of this method are more precise and correct, lack of knowledge regarding the method can prove to be a factor that results in incorrect results.

Market Drivers: Global qPCR and dPCR Market

  • Increasing adoption of qPCR and qPCR in diagnostics which has been a result of rising prevalence of infectious and genetic diseases
  • Innovations & advancements related to technology and increased investments in the market from private & public sectors; these factors are expected to drive the market growth

Market Restraints:

  • Factors such as high costs, lack of knowledge and skills for professionals are one of the major factors that act as a restraint to the market growth

Segmentation: Global qPCR and dPCR Market

  • By Technology
    • Quantitative Polymerase Chain Reaction (qPCR)
    • Digital Polymerase Chain Reaction (dPCR)
  • By Products & Services
    • qPCR Products & Services
      • qPCR Reagents and Consumables
      • qPCR Instruments
      • qPCR Software and Services
    • dPCR Products & Services
      • dPCR Reagents and Consumables
      • dPCR Instruments
      • dPCR Software and Services
    • By Application
      • qPCR Applications
        • Clinical Applications
          • Pathogen Testing
          • Oncology Testing
          • Blood Screening
          • Other Clinical Applications
        • Research Applications
        • Forensic Applications
      • dPCR Applications
        • Clinical Applications
          • Pathogen Testing
          • Oncology Testing
          • Blood Screening
          • Other Clinical Applications
        • Research Applications
        • Forensic Applications
      • By End User
        • qPCR End Users
          • Hospitals and Diagnostic Centers
          • Research Laboratories and Academic Institutes
          • Pharmaceutical and Biotechnology Companies
          • Clinical Research Organizations
          • Forensic Laboratories
        • dPCR End Users
          • Hospitals and Diagnostic Centers
          • Research Laboratories and Academic Institutes
          • Pharmaceutical and Biotechnology Companies
          • Clinical Research Organizations
          • Forensic Laboratories
        • By Geography
          • North America
          • South America
          • Europe
          • Asia-Pacific
          • Middle East & Africa

Inquiry Before Buying @

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email: [email protected]